What happened
The event date for this report is 2026-07-02. According to WHO data, there have been 1,406 confirmed cases of the disease in DRC, with 301 suspected cases and 438 deaths. The account is based on one supplied report and should be read as a record of conditions known at that point, rather than as a statement about later developments. A trial of potential treatments for the species of virus behind the current deadly Ebola outbreak in the Democratic Republic of Congo has begun, the World Health Organization (WHO) has announced.
The available figures and chronology
The first patient has been enrolled in DR Congo, WHO chief Tedros Adhanom Ghebreyesus reported on Thursday. More than 1,400 cases and 438 deaths have been confirmed in the country,, according to the WHO. These details help define the scale and immediate setting of the event without extending the evidence beyond what the supplied source states. Where a number is an estimate, provisional count, forecast or company claim, it should not be treated as a final independently audited total. The evidence packet does not support assumptions about motives, responsibility or longer-term outcomes beyond the facts described here.
The operational context
There are currently no approved vaccines or treatments for the Bundibugyo virus species of the disease, which is highly infectious. The current trial is sponsored by the WHO, and is being co-ordinated by scientists at the Institut National de Recherche Biomédicale in DR Congo, the Institute of Tropical Medicine in Belgium, and the University of Oxford in the UK. These details help define the scale and immediate setting of the event without extending the evidence beyond what the supplied source states. Where a number is an estimate, provisional count, forecast or company claim, it should not be treated as a final independently audited total. The evidence packet does not support assumptions about motives, responsibility or longer-term outcomes beyond the facts described here.
What remained uncertain
Patients was expected to be tested on two antiviral drugs. Speaking to reporters from the WHO headquarters in Geneva on Thursday, Tedros said: "Even without approved therapeutics, people are recovering from this disease, but of course, we could save many more lives with safe and effective therapeutics in our toolkit." DR Congo's. These details help define the scale and immediate setting of the event without extending the evidence beyond what the supplied source states. Where a number is an estimate, provisional count, forecast or company claim, it should not be treated as a final independently audited total. The evidence packet does not support assumptions about motives, responsibility or longer-term outcomes beyond the facts described here.
The record at the time
Taken together, the supplied material supports the main development in the headline and the specific details above. It does not establish what happened after 2026-07-02, and no later outcome is inferred here. The report therefore preserves the event-date framing, attributes the account to the available evidence and avoids turning an early figure or stated plan into a settled result. Further official data, technical findings or independent reporting could refine the picture, but those materials were not part of this packet.
